Stay updated on Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:25:47.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a change in the completion date of the study 'Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID' from 2022-09-28 to 2023-02-01. This change represents an update in the study's progress and timeline for assessing the efficacy and safety of the treatment.
    Difference
    0.1%
    Check dated 2024-06-06T14:41:36.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' with additional details on general health conditions and prior treatments. The new text also includes a description of the informed consent process required for study participation.
    Difference
    41%
    Check dated 2024-05-22T21:25:22.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:23:40.000Z thumbnail image

Stay in the know with updates to Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial page.